SUMO1P1

Across TCGA patient cohorts, SUMO1P1 RNA expression is significantly associated with the go_rna of many other GO terms, with 6,981 significant associations in total. THYM shows the largest number of these associations.

The most reproducible SUMO1P1-associated GO terms across cancer lineages are Negative regulation of leukocyte proliferation, Lymphocyte activation involved in immune response, and Cell surface receptor signaling pathway via STAT. Each is linked with SUMO1P1 in more than 21 cancer types. Because this analysis shows association rather than direction, both SUMO1P1-to-partner and partner-to-SUMO1P1 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Negative regulation of leukocyte proliferation grouped by SUMO1P1-low versus SUMO1P1-high in SKCM.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (SUMO1P1→partner) and Y-score (partner→SUMO1P1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	Negative regulation of leukocyte proliferation →	+0.040	+0.126	<.001	<.001	3	21
ESCA	Lymphocyte activation involved in immune response →	+0.048	+0.560	.001	.003	2	21
ESCA	Cell surface receptor signaling pathway via STAT →	+0.039	+0.633	<.001	.002	1	22
SKCM	Positive regulation of immune effector process →	+0.025	+0.134	<.001	<.001	3	19
LUAD	Regulation of production of molecular mediator of immune response →	+0.025	+0.174	<.001	<.001	3	19
ESCA	Regulation of leukocyte mediated immunity →	+0.040	+0.672	.001	.002	1	21

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,981 associations by consensus.

Negative regulation of leukocyte proliferation by SUMO1P1 expression — SKCM

Explore this box plot interactively →